Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Miraculins Inc V.MOM

Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s):  MCUIF

Miraculins Inc is engaged in the acquisition and development of diagnostic opportunities in areas where there are unmet clinical needs. The Company's primary technology program is in the area of diabetes.
Price: $0.08 | Change: $0.00 | %Change: 0.00%
Volume: 128,100 | Day High/Low: 0.08/0.08 | 52 Week High/Low: 0.37/0.075
View modes: 
5 stars

RE:ADA: Presented on Saturday, June 6, 2015 11:30 AM

GianniM1 wrote: Serum Protein Glucosepane and Skin Intrinsic Fluorescence Are increased in Youth with Type 1 Diabetes   View ePoster  Map Pediatrics - Type 1 Diabetes   Author(s...read more
5 stars

ADA: Presented June 6 9:15 AM

Advanced Glycation Endproducts (AGEs) Are Already Elevated in Obese Children at Diagnosis of Type 2 Diabetes (T2D) View session detail Author Block: LILADHAR KASHYAP, ABDULHAMEED ALSAHEEL, EILEEN...read more
5 stars

ADA: Presented on Saturday, June 6, 2015 11:30 AM

Serum Protein Glucosepane and Skin Intrinsic Fluorescence Are increased in Youth with Type 1 Diabetes   View ePoster  Map Pediatrics - Type 1 Diabetes   Author(s):  RUBY JOSHI BATAJOO...read more
5 stars

ADA: Presented on Monday, June 8, 2015 12:00 PM

Meta-GWAS Identifies a Second Locus Associated with Skin Intrinsic Fluorescence   View ePoster  Ask the Author Map Genetics - Type 1 Diabetes   Author(s):  DELNAZ ROSHANDEL, RONALD KLEIN,...read more
5 stars

ADA: Presented on Sunday, June 7, 2015 12:00 PM

Skin Advanced Glycation End Products (AGE) Fluorescence Identifies Abnormal Glucose Tolerance Independent of Levels of HbA1c and Soluble Receptor for Advanced Glycation End Products (sRAGE...read more
0 stars

RE:SCOUT finds ~20% more patients with disease or precursors...

Dont know how to post pdf..  Hopefully this works http://professional.diabetes.org/Content/Posters/2006/p897-P.pdf GianniM1 wrote: Have you all seen this?  study when it was "Veralight"....  rate and reply
0 stars

SCOUT finds ~20% more patients with disease or precursors...

Have you all seen this?  study when it was "Veralight"....  rate and reply
0 stars

RE:RE:RE: Scout(R) Research Receives Attention at Recent American....

Does anyone have any reason why it took a month to get this info out?  One would want to believe that investor relations would have had this out long ago.  rate and reply
5 stars

RE:RE: Scout(R) Research Receives Attention at Recent American....

This is really good news and a BIG win..... and a step towards that miracle you ask about, imo. The FACT that the Scout and the ADA are finally being referenced together .... is a giant step.  When...read more
3.5 stars

RE: Scout(R) Research Receives Attention at Recent American....

That is a nice little tidbit and a great way to start a new week. Will that news produce the miracles we want here?..maybe not just yet but I for one expect some very positive developments here before...read more
5 stars

Scout(R) Research Receives Attention at Recent American....

Scout(R) Research Receives Attention at Recent American Diabetes Association Scientific Sessions Clinical evidence includes Scout® Scores being elevated in diabetic youth WINNIPEG, MANITOBA...read more
3 stars

RE:RE:RE:RE:RE:RE:RE:RE:52 week low.

Share consolidations - the dreaded reverse split - is an exit sign. Seen countless situations where S/P descends to pre-consolidation price.  rate and reply
1 star

RE:RE:RE:RE:RE:RE:RE:RE:52 week low.

Ya I agree either way the shareholders r faked. But u can recoup in yfi  rate and reply
5 stars

RE:RE:RE:RE:RE:RE:RE:52 week low.

Bankrupcty is certainly an entity that has to be placed on the table.  At the present time, no money, no revenue, no approvals, no endorsments from CDA or WHO. As a shareholder, I'm seeing this for a...read more
5 stars

RE:RE:RE:RE:RE:RE:RE:52 week low.

In September, Miraculins received the first payment under your agreement with Hong Kong’s Catalyn Medical Technologies for the sale and distribution of Scout DS® in China. When do you think Miraculins...read more
0 stars

RE:RE:RE:RE:RE:RE:52 week low.

My point exactly. More dilution is the problem. I was just wondering why he thinks its going bankcrupt.  rate and reply
0 stars

RE:RE:RE:RE:RE:52 week low.

They won't go bankrupt because they will just raise money from the market by PP like always. The only thing that is stopping them from closing the deal is if the product is not fda approved in china...read more
0 stars

RE:RE:RE:RE:52 week low.

Curious. What are the signs of bankruptcy you speak of?  rate and reply
0 stars

RE:RE:RE:52 week low.

China is worth $90M but there are no guarantees. MOM is showing all the signs of bankruptcy.   Gad, I hope I'm wrong but I've been here before with another company that had a great product but the...read more
3 stars

RE:RE:52 week low.

plus I couldn't care less if this hits .06 tomorrow as we all know that the China deal is worth $90m as agreed. It's not a matter of if it will happen, it's WHEN it will happen. 2016 is expected, so...read more